Granulomatous Disease

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease [Phase 1]

  Phase 1 trial update on stem cell transplantation after low-intensity chemotherapy for Chronic Granulomatous Disease has completed. The snip…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Diagnostic Effectiveness of Virtual Bronchoscopy [Phase 1]

  Phase 1 clinical trial update evaluating the diagnostic effectiveness of virtual bronchoscopy for lung-related diseases.

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood [Phase 4]

  A Phase IV study evaluating recombinant human gamma interferon in children with Chronic Granulomatous Disease has completed.

• CLINICAL_TRIALS research · 2008-03-04
  Clinical Trial Update: Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders

  This completed clinical trial update investigates learning and behavior problems in children with chronic granulomatous disease and related …

• CLINICAL_TRIALS research · 2007-11-28
  Clinical Trial Update: Gene Therapy for Chronic Granulomatous Disease [Phase 1, Phase 2]

  Update on a phase 1/2 clinical trial evaluating a gene therapy for chronic granulomatous disease.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-01-26
  FDA Approved: ACTIMMUNE — Supplemental Application (Horizon Therapeutics USA, Inc.)

  FDA approved a supplemental application for ACTIMMUNE (interferon gamma-1b) submitted by Horizon Therapeutics USA, Inc.